Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues
AssigneePharmexa A/S
InventorsTorben Halkier, Søren Mouritsen, Steen Klysner
Life of this patent
Estimating the term…
Loading patent…
AssigneePharmexa A/S
InventorsTorben Halkier, Søren Mouritsen, Steen Klysner
Estimating the term…
Disclosed are novel methods for increasing muscle mass by means of immunization against Growth Differentiation Factor 8 (GDF-8, myostatin). Immunization is preferably effected by administration of analogues of GDF-8 which are capable of inducing antibody production against homologous GDF-8. Especially preferred as an immunogen is homologous GDF-8 which has been modified by introduction of one single or a few foreign, immunodominant and promiscuous T-cell epitopes while substantially preserving the tertiary structure of the homologous GDF-8. Also disclosed are nucleic acid vaccination against GDF-8 and vaccination using live vaccines as well as methods and means useful for the vaccination. Such methods and means include methods for identification of useful immunogenic GDF-8 analogues, methods for the preparation of analogues and pharmaceutical formulations, as well as nucleic acid fragments, vectors, transformed cells, polypeptides and pharmaceutical formulations.
A GDF-8 analogue which is a GDF-8 polypeptide that has been modified by means of at least two substitutions of a first amino acid sequence in SEQ ID NO:
A GDF-8 analogue which is a GDF-8 polypeptide that has been modified by means of at least two substitutions of a first amino acid sequence in SEQ ID NO:
A GDF-8 analogue comprising a GDF-8 polypeptide that has been modified by at least one modification selected from the group consisting of
Dependencies are inferred from the claim text.